By Kwanwoo Jun Celltrion Inc.’s shares climbed after a merger between the biotech company and marketing affiliate Celltrion Healthcare. The South Korean biosimilar company’s stock rose as much as 20% to 241,000 won ($186.17) on Tuesday afternoon, on course for its biggest daily gain since March 31, 2020. The benchmark Kospi was up 0.6%. The…